Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), today announced that the company will host a conference call and webcast on ...

A phase 1 trial combines immunotherapy and an oncolytic virus for high-grade neuroendocrine tumors, aiming to enroll 36 patients by 2030. The trial evaluates Opdivo, Yervoy, and Seneca Valley ...

Adding the somatostatin analog lanreotide to the mTOR inhibitor everolimus significantly prolonged progression-free survival in patients with unresectable or recurrent gastroenteropancreatic ...

Aman Chauhan, M.D., leader of the Neuroendocrine Tumor Program at Sylvester Comprehensive Cancer Center, part of the University of Miami Miller School of Medicine, and associate professor of medical ...

Neuroendocrine cancer, a rare disease affecting hormone-making cells, tragically claimed the life of actor Irrfan Khan in ...

Neuroendocrine tumors, including small cell lung cancer and neuroendocrine prostate cancer, are very aggressive with high chances of spreading. However, many individuals develop resistance to few ...

My diagnosis of neuroendocrine carcinoma gave me a new perspective on life. In 2018, I was diagnosed with neuroendocrine carcinoma (NEC) in my rectum, a rare and aggressive cancer. As I researched, I ...

Neuroendocrine carcinomas (NECs), which include small-cell lung cancer (SCLC), are a highly heterogeneous group of aggressive cancers with poor prognosis, noted Martin Wermke, MD, of TU Dresden ...